1-Benzyl-4-(phenylamino)piperidine-4-carbonitrile | CAS:968-86-5

We serve 1-Benzyl-4-(phenylamino)piperidine-4-carbonitrile CAS:968-86-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-Benzyl-4-(phenylamino)piperidine-4-carbonitrile

Chemical Name:1-Benzyl-4-(phenylamino)piperidine-4-carbonitrile
CAS.NO:968-86-5
Synonyms:1-Benzyl-4-(phenylamino)piperidine-4-carbonitrile
4-anilino-1-benzylpiperidine-4-carbonitrile
4-Anilino-1-benzyl-4-piperidinecarbonitrile
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 471.5±45.0 °C at 760 mmHg
Molecular Formula C19H21N3
Molecular Weight 291.390
Flash Point 238.9±28.7 °C
 
Specification:
Appearance:Off-hite to light brown powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Remifentanyl(CAS:132875-61-7).



Contact us for information like 1-Benzyl-4-(phenylamino)piperidine-4-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Anilino-1-benzyl-4-piperidinecarbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Benzyl-4-(phenylamino)piperidine-4-carbonitrile Use and application,1-Benzyl-4-(phenylamino)piperidine-4-carbonitrile technical grade,usp/ep/jp grade.


Related News: With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved.hexane-1,6-diol manufacturer In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.Dimethyl 2-nitroterephthalate supplier According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates.2-Chlorophenylboronic acid vendor We manufacture APIs and drug manufacturers make medicines from APIs.Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.